The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
P95HER2 as a predictive marker in the phase III randomized HERNATA trial of trastuzumab and chemotherapy as first-line therapy to metastatic or locally advanced HER2-positive breast cancer.
 
Ann S. Knoop
Honoraria - Eisai; Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Pierre Fabre; Roche Pharma AG
 
Michael Andersson
Honoraria - Roche Pharma AG
Consulting or Advisory Role - Roche Pharma AG
Travel, Accommodations, Expenses - Roche Pharma AG
 
Karsten D. Bjerre
No Relationships to Disclose
 
Yi Zang
Employment - bioTheranostics
Stock and Other Ownership Interests - bioTheranostics
Patents, Royalties, Other Intellectual Property - bioTheranostics
 
Catherine A. Schnabel
Employment - bioTheranostics
Leadership - bioTheranostics
Stock and Other Ownership Interests - bioTheranostics
Patents, Royalties, Other Intellectual Property - bioTheranostics
 
Anne-Vibeke Laenkholm
Consulting or Advisory Role - DAKO
Travel, Accommodations, Expenses - Roche Pharma AG